Section 3. Longer regimens for MDR/RR-TB



Table 3.1 gives details of the grouping of medicines recommended for use in longer MDR-TB regimens; the groups are summarized here for clarity:

  • Group A = levofloxacin or moxifloxacin, bedaquiline and linezolid;
  • Group B = clofazimine, and cycloserine or terizidone; and
  • Group C = ethambutol, delamanid, pyrazinamide, imipenem–cilastatin or meropenem, amikacin (or streptomycin), ethionamide or prothionamide, and p-aminosalicylic acid.

Book navigation